Cleveland Clinic

Levita® Magnetics Achieves First Deployment of MARS™ Surgical System in a Private Institution

Retrieved on:

Thursday, April 4, 2024

Bariatric surgery, Patient, Hospital, Prostate, Magnetism, Surgeon, Cleveland Clinic, Bypass surgery, Pain, Cholecystectomy, FDA, Health, Medical imaging

MOUNTAIN VIEW, Calif., April 4, 2024 /PRNewswire/ -- Levita Magnetics, whose mission is to expand patient access to advanced surgical care, today celebrates a key advancement in minimally invasive surgery with the deployment of its MARS surgical system at a North Texas-based hospital. This marks a significant milestone as the first implementation of the MARS system in a private institution, representing a critical development in the global expansion of the technology. This expansion follows Levita's recent international introduction in Chile and its first commercial application in the U.S. at Cleveland Clinic in late 2023.

Key Points:

This marks a significant milestone as the first implementation of the MARS system in a private institution, representing a critical development in the global expansion of the technology.
"The introduction of the MARS system in Dallas represents a meaningful and impactful advancement in our surgical capabilities," said Dr. Chad Carlton.
The MARS system, an FDA-approved surgical platform, innovatively combines magnetic technology and machinery to minimize incisions, enhance visualization, and streamline laparoscopic surgery.
MARS builds on the clinical benefits of the Levita Magnetic Surgical System®, incorporating proprietary Dynamic Magnetic Positioning technology with dual surgeon-controlled arms.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

Retrieved on:

Tuesday, March 26, 2024

Arrhythmia, American Medical Association, St Davids, University of Pennsylvania, Mount Sinai Hospital, MedStar Health, Patient, PFA, Electrophysiology, University, LAA, Medical Center, Cleveland Clinic, Atrial fibrillation, Ventricular tachycardia, Physician, Cardiac electrophysiology, Vancouver General Hospital, PRA

AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points:

AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.
Live cases, which are broadcast with expert commentary from the state-of-the-art Electrophysiology Center at St. David's Medical Center, will serve as the primary teaching tool.
The Texas Cardiac Arrhythmia Institute features the leading robotic electrophysiology center in North America.
The 72,000-square-foot center, which opened in 2019, includes six electrophysiology labs equipped with advanced technology for treatment of complex arrhythmias.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

Retrieved on:

Tuesday, March 26, 2024

AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points:

AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.
Live cases, which are broadcast with expert commentary from the state-of-the-art Electrophysiology Center at St. David's Medical Center, will serve as the primary teaching tool.
The Texas Cardiac Arrhythmia Institute features the leading robotic electrophysiology center in North America.
The 72,000-square-foot center, which opened in 2019, includes six electrophysiology labs equipped with advanced technology for treatment of complex arrhythmias.

Mayfield, OH's, Exceptional Smiles at Landerbrook Selected as a 2024 Top Patient Rated Dentist

Retrieved on:

Friday, March 22, 2024

Dental care, Dental implant, Attention, Private practice, Patient, Cleveland Clinic, Rutgers University, Multimedia, Dentist, University of Antioquia, Dentistry

MAYFIELD HEIGHTS, Ohio, March 22, 2024 /PRNewswire-PRWeb/ -- Conveniently located at 5825 Landerbrook Drive Suite #121 in Mayfield Heights, Ohio, Exceptional Smiles at Landerbrook is a well-respected dental practice known for its commitment to providing state-of-the-art dentistry with a personal touch. Exceptional Smiles at Landerbrook has been named a 2024 Top Patient Rated Dentist by Find Local Doctors, a reputable online directory that recognizes outstanding medical providers and dentists based on superior reviews and ratings from patients. The clinic offers a wide range of dental services, including general dentistry, restorative procedures, cosmetic treatments and emergency dental care. The practice is equipped to handle all types of dental needs, from routine cleanings and root canals to Invisalign, dental implants and more. In addition to their comprehensive services, Exceptional Smiles at Landerbrook goes above and beyond to make dental care convenient and enjoyable for patients. With same-day appointments, extended weekday hours and flexible payment options, the practice strives to give patients the attention and care they deserve.

Key Points:

MAYFIELD HEIGHTS, Ohio, March 22, 2024 /PRNewswire-PRWeb/ -- Conveniently located at 5825 Landerbrook Drive Suite #121 in Mayfield Heights, Ohio, Exceptional Smiles at Landerbrook is a well-respected dental practice known for its commitment to providing state-of-the-art dentistry with a personal touch.
Exceptional Smiles at Landerbrook has been named a 2024 Top Patient Rated Dentist by Find Local Doctors , a reputable online directory that recognizes outstanding medical providers and dentists based on superior reviews and ratings from patients.
The clinic offers a wide range of dental services, including general dentistry, restorative procedures, cosmetic treatments and emergency dental care.
In addition to their comprehensive services, Exceptional Smiles at Landerbrook goes above and beyond to make dental care convenient and enjoyable for patients.

Discover Your Perfect Home on Match Day with The Hiatus by My Place Group

Retrieved on:

Thursday, March 14, 2024

The Hiatus, Cleveland Clinic

Match Day marks a pivotal moment in the lives of medical professionals, where decisions made will shape their careers and lives for years to come.

Key Points:

Match Day marks a pivotal moment in the lives of medical professionals, where decisions made will shape their careers and lives for years to come.
"As one of the highest-ranked management companies in Cleveland, My Place Group, and The Hiatus, is committed to providing exceptional service and quality living spaces for our residents," said Svetlana Kertesz, COO of My Place Group.
"We understand the importance of finding the perfect home, especially during significant milestones like Match Day, and we're here to help make that transition as seamless as possible at The Hiatus."
Contact our leasing office today at 216.333.6321 or email us at [email protected] to schedule a virtual or in-person tour and take advantage of our exclusive March Match Day Specials.

Circadia Health, Cleveland Clinic Research Collaboration Shows Predictive Power of Continuous Respiratory Monitoring in Prediction of Clinical Deterioration in COVID-19

Retrieved on:

Wednesday, March 13, 2024

Research, COVID-19, Vital signs, Respiratory rate, Patient, C100, University, SARS-CoV-2, Infection, Cleveland Clinic, Outcome, LOS, FDA, Outcomes research, Health, Frontiers in Medicine

LOS ANGELES, March 13, 2024 /PRNewswire-PRWeb/ -- Continuous monitoring of respiratory rate of patients admitted with Covid-19 using contactless technology demonstrates the ability to predict those at high risk of clinical deterioration up to 24 hours in advance, in a study recently published in Frontiers in Medicine (https://doi.org/10.3389/fmed.2023.1243050).

Key Points:

The study, conducted in collaboration with the Cleveland Clinic, demonstrates Circadia Health's C100 system's ability to offer continuous, contactless respiratory monitoring, predicting clinical deterioration 24 hours in advance and enhancing patient care.
In a landmark study, a collaboration between Circadia Health, Cleveland Clinic, and the University of Barcelona utilised the Circadia Health C100 system to monitor patients with respiratory symptoms of SARS-CoV-2 (COVID-19) severe enough to warrant admission to hospital.
The C100 system provides continuous respiratory rate monitoring without the need for patient contact, providing respiratory rate data every three seconds.
The standard vital sign relating to respiratory function, intermittent respiratory rate measurement, was not predictive of subsequent decline.

MCG Recognizes CareSource with 2023 Richard L. Doyle Award for Transforming Inpatient Authorization Workflows

Retrieved on:

Tuesday, March 12, 2024

Organization, Innovation, Citation, Collaborative Care, Medicine, Communication, Health, Hospital, MCO, Cleveland Clinic, Hearst Communications, CareSource, EHR, Collection, MCG

DAYTON, Ohio, March 12, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, has named CareSource a recipient of its 2023 Richard L. Doyle Award for Innovation and Leadership in Healthcare. The nonprofit managed care organization (MCO) was recognized for successfully collaborating with hospitals to transform the inpatient authorization process.

Key Points:

The nonprofit managed care organization (MCO) was recognized for successfully collaborating with hospitals to transform the inpatient authorization process.
MCG Health President and CEO, Jon Shreve said, "We congratulate CareSource on receiving the Doyle Award as it reflects their collaborative nature and technological determination.
In addition to MCG Cite for Collaborative Care, CareSource continues to drive provider adoption through its provider portal that leverages MCG Cite AutoAuth technology.
CareSource processes 73% of eligible authorization types through its provider portal; because of MCG Cite AutoAuth technology, CareSource can respond to 20-30% of a provider's requests during the provider's initial interaction with the CareSource Portal.

Lamassu Awarded NIH Grant For Breakthrough Cancer Treatment

Retrieved on:

Tuesday, March 12, 2024

CLEVELAND, March 12, 2024 /PRNewswire/ -- Lamassu Bio Inc., a cutting-edge biotech company dedicated to innovative cancer therapies, has been awarded a grant from the National Institutes of Health (NIH) and National Cancer Institute ( NCI) for the development of their groundbreaking treatment for p53 wild-type sarcomas. The $2.05 million grant will help fund the clinical trial integral to this new cancer treatment. The trial will be conducted in collaboration with Cleveland Clinic Taussig Cancer Center and Cleveland Clinic Children's Pediatric Hematology and Oncology Department.

Key Points:

The $2.05 million grant will help fund the clinical trial integral to this new cancer treatment.
Its role in preventing tumor formation by inducing programmed cell death in response to cellular stress makes it a key target for cancer therapy.
This innovative approach offers promising prospects for addressing chemo-resistant cancer and presents a significant pathway for advancing cancer care.
"The NIH grant will play a pivotal role in facilitating the transition of our research from the laboratory to the bedside.

Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials

Retrieved on:

Tuesday, March 12, 2024

Prevalence, Kaiser, Multiple sclerosis, Alzheimer's disease, Partnership, Patient, Eye, Cleveland Clinic, Clinical trial, DRS, Fluorescein angiography, Therapy, Diabetic retinopathy, Ophthalmology, Medical imaging

PHILADELPHIA, Pa., March 12, 2024 /PRNewswire/ -- Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced a strategic partnership with the Cleveland Clinic's renowned Cole Eye Institute. The partnership brings Cleveland Clinic's ophthalmology imaging expertise and AI-driven analysis platforms together with Clario's industry-leading vendor-agnostic image management system. The collaboration will support clinical trials evaluating the efficacy of therapeutics designed to treat the eye as well as other trials monitoring ophthalmic safety events.

Key Points:

Strategic partnership helps sponsors overcome common clinical trial challenges and drive critical ophthalmic advances in treatment for patients.
PHILADELPHIA, Pa., March 12, 2024 /PRNewswire/ -- Clario , a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced a strategic partnership with the Cleveland Clinic's renowned Cole Eye Institute.
The partnership brings Cleveland Clinic's ophthalmology imaging expertise and AI-driven analysis platforms together with Clario's industry-leading vendor-agnostic image management system.
To learn more about Clario and its broad range of solutions offerings for the ophthalmology therapeutic area, please visit https://clario.com/therapeutic-areas/ophthalmology/ .

Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials

Retrieved on:

Tuesday, March 12, 2024

PHILADELPHIA, Pa., March 12, 2024 /PRNewswire/ -- Clario, a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced a strategic partnership with the Cleveland Clinic's renowned Cole Eye Institute. The partnership brings Cleveland Clinic's ophthalmology imaging expertise and AI-driven analysis platforms together with Clario's industry-leading vendor-agnostic image management system. The collaboration will support clinical trials evaluating the efficacy of therapeutics designed to treat the eye as well as other trials monitoring ophthalmic safety events.

Key Points:

Strategic partnership helps sponsors overcome common clinical trial challenges and drive critical ophthalmic advances in treatment for patients.
PHILADELPHIA, Pa., March 12, 2024 /PRNewswire/ -- Clario , a healthcare research and technology company that delivers the leading endpoint technology solutions for clinical trials, today announced a strategic partnership with the Cleveland Clinic's renowned Cole Eye Institute.
The partnership brings Cleveland Clinic's ophthalmology imaging expertise and AI-driven analysis platforms together with Clario's industry-leading vendor-agnostic image management system.
To learn more about Clario and its broad range of solutions offerings for the ophthalmology therapeutic area, please visit https://clario.com/therapeutic-areas/ophthalmology/ .